Q32 Bio (QTTB) Accumulated Depreciation & Amortization (2017 - 2026)

Q32 Bio has reported Accumulated Depreciation & Amortization for 10 years, with the latest figure at $1.9 million in Q1 2026.

• For the quarter ending Q1 2026, Accumulated Depreciation & Amortization rose 23.03% year-over-year to $1.9 million; the trailing twelve-month figure through Mar 2026 stood at $1.9 million (up 23.03% YoY), and the FY2025 full-year result was $1.8 million, up 26.91% from the prior year.
• Accumulated Depreciation & Amortization for Q1 2026 stood at $1.9 million, up from $1.8 million in the prior quarter.
• The five-year high for Accumulated Depreciation & Amortization was $6.8 million in Q3 2022, with the low at $966000.0 in Q4 2023.
• Average Accumulated Depreciation & Amortization over 5 years is $3.3 million, with a median of $1.8 million recorded in 2025.
• Year-over-year, Accumulated Depreciation & Amortization tumbled 84.51% in 2023 and soared 50.41% in 2024.
• Tracing QTTB's Accumulated Depreciation & Amortization over 5 years: stood at $6.2 million in 2022, then plunged by 84.51% to $966000.0 in 2023, then surged by 50.41% to $1.5 million in 2024, then advanced by 26.91% to $1.8 million in 2025, then rose by 4.88% to $1.9 million in 2026.
• The last three Accumulated Depreciation & Amortization figures came in at $1.9 million (Q1 2026), $1.8 million (Q4 2025), and $1.8 million (Q3 2025), per Business Quant data.

Peer Comparison